logo

EDWARDS LI(NYSE:EW)
Edwards Lifesciences Corp. a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company''s global brands, which are sold in approximately hundred countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office.
# Employees: 6200
Address: One Edwards Way,Irvine,CA,USA
Phone: 949 250-2500
Fax: 949-250-2525
Website: www.edwards.com
Email: investor_relations@edwards.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Michael A. Mussallem (Chmn.; C.E.O.)
Thomas M. Abate (Corp. V.P.; C.F.O.; Treas.)
Robert A. Ingram (Dir.)
Mike R. Bowlin (Dir.)
Vernon R. Loucks Jr. (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/9/2010
Mean EPS (Next Qtr): $0.84
Mean EPS (Year): $3.05
Mean Estimate(Long Term): $15.79
P/E Ratio(Based on EPS estimate): 26.650
Number of Estimates: 23
Shares Performance
Period EW Compare to S&P
YTD 47.86 % 22.37 %
4 Weeks 6.91 % 5.75 %
12 Weeks 30.80 % 23.31 %
Shares Information
Analyst Coverage: Y
Avg Volume: 394484
Shares Outstanding: 56M
Market Cap: $4.58B
52 Week High: $81.80
52 Week Low: $45.00
P/E Ratio: 27.080
PEG Ratio: 1.690
Split: On 1/1/1990 EW split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -12.35 %
EPS Growth in Last Year: 26.79 %
Sales Growth in Last Quarter: -2.92 %
Sales Growth in Last Quarter: 7.28 %
Financials
Qtr Book Value: $4.20
Cash Flow/Share: $21.97
Change in Payout Ratio: 0.000
Price/Sales: 3.570
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia